ChemInform Abstract: HIV Protease (HIV PR) Inhibitor Structure‐Activity‐Selectivity, and Active Site Molecular Modeling of High Affinity Leu(CH(OH)CH2)Val Modified Viral and Nonviral Substrate Analogs.

Abstract

1993 pharmacology, medicinal chemistry, vaccines, serums pharmacology, medicinal chemistry, vaccines, serums V 1100 07 -301 HIV Protease (HIV PR) Inhibitor Structure-Activity-Selectivity, and Active Site Molecular Modeling of High Affinity Leu(CH(OH)CH2)Val Modified Viral and Nonviral Substrate Analogs. --(SAWYER, T. K.; STAPLES, D. J.; LIU, L.; TOMAS-SELLI, A. G.; HUI, J. O.; O'CONNELL, K.; SCHOSTAREZ, H.; HESTER, J. B.; MOON, J.; HOWE, W. J.; SMITH, C. W.; DECAMP, D. L.; CRAIK, C.; DUNN, B. M.; LOWTHER, W. T.; HARRIS, J.; POORMAN, R. A.; WLODAWER, A.; JASKOLSKI, M.; HEINRIKSON, R. L.; Int.